CN108635332A - A kind of preparation method of voglibose particle - Google Patents
A kind of preparation method of voglibose particle Download PDFInfo
- Publication number
- CN108635332A CN108635332A CN201810863323.1A CN201810863323A CN108635332A CN 108635332 A CN108635332 A CN 108635332A CN 201810863323 A CN201810863323 A CN 201810863323A CN 108635332 A CN108635332 A CN 108635332A
- Authority
- CN
- China
- Prior art keywords
- voglibose
- solution
- preparation
- particle
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention provides a kind of preparation methods of voglibose particle, the particle is prepared by a step prilling, friability is low, roundness is good, voglibose energy Fast Stripping therein, and content uniformity is preferable, suitable for capsule, tablet (including dispersible tablet and oral disintegrating tablet), granule is further made.It is to be added to voglibose in the polar solvent of containing water-soluble adhesive, and be injected in the step comminutor containing diluent and disintegrant in such a way that top spray is granulated that it, which prepares thinking,.The preparation method is easy to operate, reduces hand labor intensity, is suitble to large-scale production.
Description
Technical field
The present invention relates to a kind of preparation methods of voglibose particle, belong to field of pharmaceutical biology.
Background technology
Diabetes are a kind of endocrine and metabolic disorders diseases, are caused by insulin secretion and Use barriers with hyperglycemia
The chronic disease being characterized.It is counted according to International Diabetes Federation (IDF), ends 2015, diabetic in global range
Have 4.15 hundred million (illness rate up to 8.8%), pre-diabetic has 3.18 hundred million (illness rate up to 6.7%).If being not added with intervention, arrive
The year two thousand forty diabetic will be up to 6.42 hundred million, and prediabetes crowd will be up to 4.81 hundred million.Wherein, in 4.15 hundred million diabetics
There is 46.5% crowd not to be diagnosed.There are 5,100,000 people to die of diabetes related diseases every year, accounts for the 8.39% of total death toll.
It is predicted according to the World Health Organization (WHO), medical expenses of the whole world in 2016 for diabetes will reach 53,000,000,000 dollars, only
It comes second inferior to tumour.Therefore, the research and development of diabetes medicament not only have high commercial value, more have to human health
Very huge meaning.
Being continuously increased for diabetes number is mainly derived from type 2 diabetes patient, and morbidity is usually associated with a series of next
It such as smokes derived from the risk factor of bad life habits, is fat, bad diet, not getting enough athletic exercise.α-glucosidase inhibitors medicine
Object (the representative drug such as listed has acarbose, voglibose and Miglitol) has enteral alpha-glucosidase
Inhibiting effect can delay simultaneously largely to reduce postprandial grape of the carbohydrate in enteral digestion to reduction of patient
Sugared pressure.Different alpha-glucosidases in small intestine have its substrate specificity.As oligosaccharides can quilt by α-amylasehydrolysis, maltose
Maltose or sucrose enzyme hydrolysis, sucrose can further hydrolyze generation glucose by sucrose enzyme hydrolysis, maltose, and sucrose can water
Solution generates glucose or fructose.The digestion for blocking due to it and non-fully carbohydrate, it is normal daily can to meet patient
Energy requirement.There is different alpha-glucosidases different substrate specificities, ideal hypoglycemic medicine to be while efficiently block shallow lake
Powder, maltose and sucrose hydrolysis can generate the preferable purpose for reducing postprandial blood sugar at the process of glucose.
Voglibose is to be pressed down by the alpha-glucosidase of new generation that Japanese Takede Chemical Industries Ltd develops
Preparation (Curr Med Chem, 2006,13 (1), 109-116), is the amino sugar analog found from unwrapping wire bacteria culture fluid.
Voglibose tablet or dispersible tablet trade nameOrIt is listed for the first time in Japan within 1994,1998 in South Korea
City, 1999 in Discussion on Chinese Listed, in multiple national list marketings.
Disaccharide class hydrolysis in the inhibition enteron aisle of Antagonism can be competed after oral voglibose, to delay disappearing for carbohydrate
Change and absorb, to improve postprandial hyperglycemia, while the fasting blood-glucose and saccharification blood of type 2 diabetes patient can also be effectively reduced
Red eggs white level (Shanghai medicine, 2013 (1):18-21).It does not stimulate insulin secretion, this point is different from sulfonylureas, and current
Unlike clinical widely used biguanides:Voglibose delays rather than inhibits digesting and assimilating for carbohydrate, and therefore, it has
There is unique hypoglycemic effect.
Voglibose as antidiabetic drug has stringent application method, it is necessary to could effectively being administered orally before meals
Control postprandial blood glucose levels.The present invention is that voglibose is prepared into the particle with fater disintegration, Fast Stripping, should
Particle can be used for further being made capsule, tablet, granule, and main purpose is to make voglibose fast quick-release in vivo
Put, shorten it is oral after to playing soak time in drug effect this segment body, fast onset drug effect, to efficiently control postprandial blood
Sugar.If to reach above-mentioned purpose, first, must have the feature that disintegration is fast, dissolution rate is high outside prepared granule;Its
Secondary, uniformity of dosage units has to conform to quality requirements, since voglibose dosage is smaller (only 0.2 or 0.3mg), if content is equal
Evenness cannot be protected, then be difficult effectively to control postprandial blood sugar.
First, voglibose is white crystalline powder, although itself is water-soluble, (solubility reaches in water very well
26.73mg/mL), according to well known to a person skilled in the art common sense, its dissolution rate of water soluble drug should be easy to solve, but right
For voglibose, it appears that fail to agree with above-mentioned theory, facts proved that, for voglibose conventional tablet, the body of 30min
Outer dissolution rate only has 83% or so (document CN200710129313.7), it may be possible to since raw material crystalline form is the needle-shaped of matrix arrangement
Structure (document CN201010100033.5).
To solve the problems, such as the dissolution of voglibose, there is patent to propose and dispersible tablet, oral film is made in voglibose
The dosage forms such as agent, oral disnitegration tablet.Also patent (such as CN201410854236.1) proposes voglibose micronization processes again
Prepare piece agent.
Describing such as patent CN200710129313.7 and CN200710305247.4 and prepare voglibose dispersible tablet
Method.The preparation method of patent CN200710129313.7 is first voglibose to be added in polar solvent solution is made, then
Be added in the mixture containing filler and disintegrant, wet granulation, it is dry, last additional disintegrant and lubricant prepare and
.Patent CN200710305247.4 is the method prepared composition discrete piece using conventional tablet.
Voigelibo is prepared as CN201010100033.5, CN201610516869.0 and EP1561458 patent propose
The method of sugared film.CN201010100033.5 is that voglibose is highly dispersed at plasticizer-containing, corrigent and titanium dioxide
Polyvinyl alcohol or hydroxypropylcellulose or polyoxyethylene water-soluble high-molecular material in;CN201610516869.0 is at the former
On the basis of be added to increase permeability as sodium salicylate, edetate, NaTDC, oleic acid, octanoic acid, sodium salicylate,
One or more penetrating agents such as lauryl sodium sulfate, polyoxyethylene lauryl base ester, azone.EP1561458 is then system
Standby two film layers, one layer be supporting layer that thickness is 15 μm, the drug containing that another layer is 30 μm for the thickness containing voglibose
Layer.
As CN99808969.9 discloses voglibose oral disintegrating tablet preparation method.The patent thinks to prepare the pass of oral disintegrating tablet
Key technology is to prepare crucial auxiliary material, i.e., a kind of to have immediately disintegrable, intensity appropriate and the low-substituted hydroxypropyl without harsh feeling
Cellulose.
Also there are document (modern medicine health, 2017,33 (14):The method that equivalent is progressively increased 2107-2109) is used directly will
Raw material is mixed with auxiliary material, and the Voglibose tablet to conform to quality requirements can be made using direct compression method.
Since voglibose dosage is smaller, common method is difficult to ensure its uniformity of dosage units, granule content fluctuation compared with
(such as larger than 5%) greatly.In order to make particle there is preferable uniformity, CN201210580191.4 patents to propose voigelibo first
Sugar is gradually mixed with a certain proportion of starch, wet granulation, and dry, whole grain obtains, and is finally prepared to tablet, this method is different
Voglibose tablet (modern medicine health, 2017,33 (14) are prepared in traditional equivalent gradually-increased:2107-2109).
Therefore, for the oral preparation of voglibose, how to solve its dissolution rate and content uniformity two large problems is
Put a difficult problem in face of most of voglibose preparations producer.
Invention content
Present invention aims at a kind of preparation method of voglibose particle is provided, the purpose is to so that the particle is had soon
It is instant go out, and preferable dual characteristics of content uniformity, the particle suitable for be further made capsule, tablet (including oral disintegrating tablet,
Dispersible tablet), granule.
The present invention provides a kind of preparation method of voglibose particle, which is made using a step prilling,
Include the following steps:
(1) water-soluble binder is dissolved in polar solvent, solution A is used as after evenly dispersed;
(2) solution A is divided into two parts, for a copy of it as A-1, the evenly dispersed rear conduct of voglibose is added in another
Solution A -2;
(3) diluent and disintegrant are taken, is added in a step comminutor, mixing;Control wind turbine frequency:20Hz~30Hz;It is mixed
Close the time:5~30min.
(4) solution A -1 is taken to be injected in the step comminutor described in above-mentioned (3) in such a way that top spray is granulated;Control wind
20~30Hz of unit frequency, 40~85 DEG C, 0.15~0.25Mpa of atomisation pressure, 20~80rpm of wriggling revolution speed of inlet air temperature.
(5) dry after having sprayed above-mentioned solution A -1, until pellet moisture≤4.0%.Wind turbine 20~30Hz of frequency is controlled, into
40~85 DEG C of air temperature.
(6) solution A -2 is taken to be injected in the step comminutor described in (4) in such a way that top spray is granulated;Control wind turbine frequency
20~30Hz of rate, 40~85 DEG C, 0.15~0.25Mpa of atomisation pressure, 20~80rpm of wriggling revolution speed of inlet air temperature.
(7) dry after having sprayed above-mentioned solution A -2, until pellet moisture≤4.0%;Wind turbine 20~30Hz of frequency is controlled, into
40~85 DEG C of air temperature.
The present invention provides a kind of preparation method of voglibose particle, water-soluble binder is povidone, hydroxypropyl fibre
Dimension element, one kind in hydroxypropyl methylcellulose and its a variety of mixtures.
The present invention provides a kind of preparation method of voglibose particle, polar solvent is water, ethyl alcohol, isopropanol, third
One kind in ketone and its a variety of mixtures.
The present invention provides a kind of preparation method of voglibose particle, diluent is the lactose sieved with 100 mesh sieve, sweet dew
One kind in alcohol, xylitol, trehalose, microcrystalline cellulose and its a variety of mixtures.
The present invention provides a kind of preparation method of voglibose particle, disintegrant is the starch sieved with 100 mesh sieve or pre-
Gelling starch.
The present invention provides a kind of preparation method of voglibose particle, the usage amount of voglibose is 1 part, water-soluble
Property adhesive be 5~100 parts (weight ratios, similarly hereinafter), preferably 10~80 parts, more preferably 15~60 parts;Polar solvent is 100
~2000 parts, preferably 200~1500 parts, more preferably 300~1000 parts;Diluent be 200~1000 parts, preferably 250
~800 parts, more preferably 300~700 parts;Disintegrant is 10~1000 parts, preferably 25~800 parts, more preferably 50~500
Part.Solution A is divided into two parts of A-1 and A-2, and the ratio of this two parts of solution is 0:1 or 1:(0.2~5).
When the ratio of two parts of solution of A-1 and A-2 is 0:When 1, above-mentioned technological evolution is at following technique:
Include the following steps:
(1) water-soluble binder is dispersed in polar solvent, solution A is used as after mixing;
(2) voglibose is added in solution A, solution B is used as after evenly dispersed;
(3) diluent and disintegrant are taken, is added in a step comminutor, mixing.Control wind turbine frequency:20Hz~30Hz;It is mixed
Close the time:5~30min.
(4) solution B is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 40~85 DEG C, 0.15~0.25Mpa of atomisation pressure, 20~80rpm of wriggling revolution speed of inlet air temperature.
(5) dry after having sprayed above-mentioned solution B, until pellet moisture≤4.0%.Control wind turbine 20~30Hz of frequency, air inlet
40~85 DEG C of temperature.
In view of polar solvent is water, ethyl alcohol, isopropanol, one kind in acetone and its a variety of mixtures, therefore, needing will be into
Air temperature controls in a certain range.The composition of polar solvent is different, and the range of control also should difference.In addition, experiment is also
It was found that inlet air temperature is related with temperature of charge, leaving air temp, these three temperature need to maintain a balance, under normal circumstances, object
Conveniently at 28~35 DEG C, leaving air temp control is appropriate at 25~32 DEG C for the control of material temperature degree.
Furthermore, it is contemplated that intragranular disintegrant be starch or pregelatinized starch, due to disintegrant type and dosage not
Together, the moisture of final material control is also answered different.Under normal circumstances, pellet moisture control obtained is in 4% range.Due to
Starch or the material of the strong moisture absorption of pregelatinized starch, under the larger environmental condition of relative humidity, material moisture is larger;Simultaneously because
Lactose or mannitol are all the materials for being not easy the moisture absorption, when starch or smaller pregelatinized starch dosage, pellet moisture control obtained
System should tighten, if any control in 3% range, what is had should control in 2.5% range.
The present invention provides a kind of preparation methods of voglibose particle, after having sprayed A-1 solution, wait for dry materials to water
A-2 solution is sprayed again after point designated value, the purpose is to:(1) if spray velocity is very fast, granular grows are also very fast, it is easy to form one
A little larger particles, the bulk density of material are smaller;After having sprayed A-1 solution, for a period of time by dry materials, material is dry in boiling
Due to constantly moving during dry, particle has the tendency that grain size reduction, can increase the mouthfeel of Orally disintegrating tablet, is unlikely to too thick
It is rough.(2) after material first dries a period of time, the moisture evaporation inside particle is come out, will not be mingled in follow-up coating in this way
Unevaporated " internal moisture ", such particle easily parches, and is conducive to subsequent operation.
The present invention provides a kind of preparation methods of voglibose particle, if being further prepared into tablet or particle, also
The lubricant (such as 0.5% magnesium stearate) of obtained particle gross weight 0.3%~1.0% and/or 0.1%~2.0% help need to be added
Flow agent (such as 0.2% gaseous silicon oxide).
Another object of the present invention is to provide a kind of preparation methods of Voglibose tablet:According to described one kind
Lubricant (such as 0.5% stearic acid that particle gross weight 0.3%~1.0% is made is added in the preparation method of voglibose particle
Magnesium) and/or 0.1%~2.0% glidant (such as 0.2% gaseous silicon oxide).
Another object of the present invention is to provide a kind of preparation methods of voglibose dispersible tablet:According to described one
The preparation method of kind voglibose particle, also needs 10~200 parts additional of disintegrant;Disintegrant is typically chosen disintegration ability
Stronger low-substituted hydroxypropyl cellulose, crospovidone, croscarmellose sodium, sodium carboxymethyl starch.
Another object of the present invention is to provide a kind of preparation methods of voglibose granule:According to described one
The preparation method of kind voglibose particle also needs to use cane sugar substitution filler therein, prepares blank granules, and according to certain
Blank granules and medicine-containing particle are mixed and made into voglibose granule by ratio.
A kind of Voglibose tablet, a kind of voglibose dispersible tablet, a kind of voglibose granule
Preparation method is:After tablet, dispersible tablet or granule is made, each preparation unit contain voglibose be 0.2mg or
0.3mg。
In order to make voglibose particle be provided simultaneously with the feature that dissolution is fast, dissolution rate is high and content uniformity is good, simultaneously
A large amount of document has been made suitable for several formulations, the present inventor such as tablet (including oral disintegrating tablet, dispersible tablet), capsule or granule is made
Investigation and optimization work.
Although oral disintegrating tablet, pelliculae pro cavo oris and dispersible tablet can solve the problems, such as that dissolution is fast, dissolution rate is high, this patent proposes
A step comminution granulation be different from the dispersion blade technolgy that patent CN200710129313.7 is proposed.I.e. in essence, both sides
The particle shape of method is different, and for the former particle shape with more spherical shape, mobility is more preferable.It is said from preparation process, after
Person is first voglibose to be added in polar solvent solution is made, and is then added to the mixing containing filler and disintegrant
It is dry by wet granulation in object, the techniques such as additional disintegrant and lubricant are added and are prepared.The identical point of two patents:All
Voglibose is dissolved in the polar solvent containing water-soluble binder, can be transferred through effectively improving due to Fu Gelie
Dissolution rate that the acicular texture of wave sugar matrix arrangement is brought is low and content homogeneity question.But this patent also has as is evident below
Advantage:
(1) production technology is simplified, the production time is shortened.The method that this patent proposes does not use wet granulation technology,
It is that material is completed to mixing, granulation and drying process directly on a step comminutor.According to wet granulation technology, material has needed
At mixing, wet granulation, these three dry independent technological operations, these operations are all unaided, be not it is integrated,
It is respectively necessary for using equipment such as mixing machine, wet granulator, vacuum feeder and boiling driers.And the preparation that this patent proposes
Method is not required to carry out material transfer on various devices, therefore shortens the entire production time, can be completed more within the unit interval
The preparation process of more preparations.
(2) it improves human resources utilization to lead, reduces hand labor intensity.Since the method that this patent proposes is not required to make
With multiple equipments such as mixing machine, wet granulator and boiling driers, operating personnel's degeneracy of three processes is at a process
Operating personnel, improve human resources utilization and lead.Since the solution containing voglibose is that gradual spray pattern is added,
Rather than be directly added according to wet granulation mode, hand labor intensity substantially reduces.
(3) this patent obtains particle friability is relatively low, roundness is more preferable, is conducive to the preparation of follow-up several formulations.According to
This patent propose operating method, particle be will contain the solution of voglibose slowly spray by way of made from, be not
Made from fluidized drying mode, obtained particle shape is more complete, and friability is relatively low, roundness is higher.According to wet granulation
In addition the combination of fluidized drying, obtained particle may be less due to the dosage of adhesive, though roundness is preferable, friability
Spend higher, broad particle distribution;The dosage of adhesive is higher, though narrower particle size distribution, friability are relatively low, roundness is bad.
Therefore, the method that this patent proposes can be further prepared into tablet, capsule and granule.If selecting different supplementary product kind collocation
It uses, it is preferably to be prepared into oral disintegrating tablet and dispersible tablet.When such as preparing oral disintegrating tablet, mannitol and pregelatinized starch conduct are selected respectively
Filler and disintegrant when one step is granulated, while the disintegrants such as additional low-substituted hydroxypropyl cellulose and magnesium.
When such as preparing dispersible tablet, a filler when step is granulated selects mannitol, lactose, disintegrant to select starch or pregelatinized starch,
Disintegrants and the magnesium stearate lubricant such as additional low-substituted hydroxypropyl cellulose simultaneously.
These creative advantages are all because the preparation method for the voglibose particle that this patent proposes has
Prominent feature.Separate since voglibose is dispersed in polar solvent, and by water-soluble adhesive, solution second of the three ten-day periods of the hot season lattice row
After wave sugar is existing for molecular forms, to be sprayed onto the fooled polar solvent volatilization of material, since the process for losing solvent is too fast, Fu Gelie
Also have little time to reassemble between wave glycan molecule and just have become the minimum solid state of particle, since voglibose is with molecular state
It being blocked in water-soluble binder, voglibose finally exists with molecular state or microcrystalline form in obtained particle outer layer,
Voglibose dispersibility is significantly improved, dissolution rate and dissolution rate are improved.
This patent is different from the voglibose that Takede Chemical Industries Ltd proposes in CN99808969.9 patents
Oral disintegrating tablet production technology.What is proposed in CN99808969.9 patent Examples 6 is also a kind of life using fluidised bed granulator
Production. art, it is spray after mixing voglibose, mannitol, low-substituted hydroxypropyl cellulose, anhydrous citric acid and aspartic acid
Enter water to be granulated, obtain the particle of oral disnitegration tablet, disintegration time is 27 seconds.Since the dosage of voglibose is relatively low
(only 0.2mg or 0.3mg), in a large amount of material, it is difficult to be uniformly mixed, uniformity of dosage units cannot be guaranteed;Simultaneously because powder
Voglibose after broken is arranged with acicular texture, there are problems that potential dissolution rate.
This patent is also differs from Athena Drug Delivery Solutions companies of India in WO2014184806
The voglibose oral disintegrating tablet production technology of proposition.The voglibose mouth proposed in WO2014184806 patent Examples 1
Disintegrating tablet production technology is first to prepare the medicine-containing particle containing voglibose.The preparation method of the medicine-containing particle is:First by Fu Gelie
Wave sugar is dissolved in purified water, and sequentially adds mannitol, liquid flavoring banana essence, and the solution of formation is added to by mannitol and two
In the material of silica premixing, stirring, drying.
This patent is other than proposing particle and the technique being once granulated can be used, it is also proposed that the technique that can be repeatedly granulated.It is such as right
It is granulated in twice, granulation process is:The solution of containing water-soluble adhesive is first divided into two parts, Fu Gelie is added in a copy of it
Wave sugar, another is then not added with.Solution without voglibose is then first injected to filler and the disintegration of a step comminutor
In the mixed material of agent composition, the blank granules for being covered with water-soluble binder are made, then spray into again while containing voigelibo
The solution of sugar and water-soluble binder, the particle obtained in this way has apparent three-decker, respectively by filler and disintegration
The internal layer that agent is constituted, the middle layer being made of water-soluble binder, by two kinds of material structures of voglibose and water-soluble binder
At outer layer.Experiment finds that its disintegration rate of the particle of this three-decker is also faster than double-layer structure, fast suitable for being prepared into
It is instant go out dispersible tablet or oral disintegrating tablet.
For the voglibose that though water solubility is good but solution rate is slower, and the method applied in the present invention, complete gram
It has taken above-mentioned dissolution rate, dispersibility and content uniformity etc. and has seemed the difficulty that can not possibly be solved.This is one fruitful
Work.Surprisingly, it was found that first voglibose is dissolved in polar solvent appropriate, a step suitable system after being granulated
The several formulations such as standby piece agent (including oral disintegrating tablet, dispersible tablet), capsule and granule, the preparation obtained using the present invention are being provided
Dissolution rate in time is almost 100%, and uniformity of dosage units meets the quality requirement of Chinese Pharmacopoeia.
Description of the drawings
The stripping curve of Fig. 1 tablet and reference preparation made from embodiment 23~25
As seen from the figure, the dissolution rate of embodiment 23~25 slightly has difference, this may be due in prescription adhesive model with
Caused by dosage and filler and the dosage difference of disintegrant.Homemade tablet dissolved corrosion is produced with Wu Tian companies of Japan
Voglibose tablet reference preparation it is different, have the characteristics that Fast Stripping, tri- time points of 5min, 10min, 15min it is molten
Out-degree is far above reference preparation, therefore tablet obtained meets the dissolution feature for not only conforming with tablet (30min dissolves out 85% or more),
And it also is compliant with the dissolution feature (85% or more 15min dissolutions) of dispersible tablet.Since the tablet of embodiment 23~25 is by implementing
The particle preparation of example 1~3 and obtain, therefore, the characteristics of particle in Examples 1 to 3 is likewise supplied with Fast Stripping.
The stripping curve of Fig. 2 oral disintegrating tablet and reference preparation made from embodiment 26~30
As seen from the figure, the voglibose oral disintegrating tablet reference preparation that embodiment 26~30 and Wu Tian companies of Japan produce it is molten
Dissolution rate is 85% or more in 5min for out-degree, therefore tablet obtained meets dissolution feature (the 15min dissolutions 85% of oral disintegrating tablet
More than).Since the oral disintegrating tablet of embodiment 26~30 is obtained by the particle preparation of embodiment 4~8, in embodiment 4~8
Particle the characteristics of being likewise supplied with Fast Stripping.
The stripping curve of Fig. 3 capsule and reference preparation made from embodiment 31~33
As seen from the figure, homemade three batches of capsules dissolution rate in 5min is attained by 50% or more, the dissolution rate in 10min
80% or more, in 15min, dissolution rate is 85% or more, therefore capsule energy Fast Stripping obtained, has fater disintegration, quickly
The characteristics of dissolution.Since the capsule of embodiment 31~33 is after 0.5% magnesium stearate is added by the particle of 9~11 gained of embodiment
Can filling capsule be prepared, therefore, the characteristics of particle in embodiment 9~11 is likewise supplied with Fast Stripping.
The stripping curve of Fig. 4 dispersible tablet and reference preparation made from embodiment 31~33
As seen from the figure, the dissolution rate of embodiment 34~38 and reference preparation in 5min dissolution rate 90% or more, therefore
Preparation obtained meets the dissolution feature (85% or more 15min dissolutions) of dispersible tablet.Since the dispersible tablet of embodiment 34~38 is
It is prepared after 0.5% magnesium stearate is added by the particle of 12~16 gained of embodiment, therefore, the particle in embodiment 12~16
The characteristics of being likewise supplied with Fast Stripping.
The stripping curve of Fig. 5 granules made from embodiment 39~42
As seen from the figure, dissolution rate is 90% or more in 5min for the dissolution rate of embodiment 39~42, therefore particle obtained
Agent has the characteristics of Fast Stripping, and particle of the granule of embodiment 39~42 from 17~20 gained of embodiment, therefore implements
The characteristics of particle in example 17~20 is likewise supplied with Fast Stripping.
Specific implementation mode
The present invention described further below, but the practical range of the present invention is not limited.
The preparation of 1 voglibose particle of embodiment
Prescription:
Technique:
(1) by the hydroxypropylcellulose of recipe quantity (Ashland companies of the U.S., KlucelTM, LXF models) and it is dissolved in purified water (certainly
System, similarly hereinafter) in, it is used as solution A after evenly dispersed;
(2) take solution A, be added recipe quantity voglibose (Shanghai Tianwei Biological Pharmaceutical Corp., pharmaceutical grade, under
Together), evenly dispersed rear as solution B;
(3) lactose (Foremost Farms USA companies of the U.S., pharmaceutical grade, 312 models, with preceding mistake 100 of recipe quantity are taken
Mesh sieves, similarly hereinafter) and starch (Weifang Shengtai Medicine Co., Ltd., pharmaceutical grade, 200 mesh, similarly hereinafter), a step comminutor (Chongqing is added
Rising sun pharmaceutical machine device fabrication Co., Ltd of section, LBL-30 type fluidized bed granulation seed-coating machines, similarly hereinafter) in, mix 30min, control
Wind turbine frequency:20Hz~30Hz.
(4) solution B is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 45~85 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 25rpm of inlet air temperature.
(5) dry after having sprayed above-mentioned solution B, until pellet moisture≤2.5% (moisture teller, Ohaus companies,
M1345 models, determination condition:105 DEG C of 10min, similarly hereinafter).Control wind turbine 20~30Hz of frequency, 40~80 DEG C of inlet air temperature.
The preparation of 2 voglibose particle of embodiment
Prescription:
Technique:
(1) ethyl alcohol (Xuzhou Xiang Pei Wine Co., Ltd, pharmaceutical grade, a concentration of 95%, V/V, similarly hereinafter) 2.0kg is taken, is added
Purified water 18.0kg is configured to 10% ethanol (W/W).
(2) by the hydroxypropylcellulose of recipe quantity (Ashland companies of the U.S., KlucelTM, EXF models) and it is dissolved in 10% ethyl alcohol
In liquid (W/W), solution A is used as after evenly dispersed;
(3) solution A is taken, the voglibose of recipe quantity is added, solution B is used as after evenly dispersed;
(4) the newborn sugar and starch of recipe quantity is taken, is added in a step comminutor, 25min is mixed, controls wind turbine frequency:20Hz
~30Hz.
(5) solution B is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, inlet air temperature set 55~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 50rpm.
(6) dry after having sprayed above-mentioned solution B, until pellet moisture≤4.0%.Control wind turbine 20~30Hz of frequency, air inlet
65 DEG C of temperature.
The preparation of 3 voglibose particle of embodiment
Prescription:
Technique:
(1) ethyl alcohol 8.0kg is taken, purified water 12.0kg is added, is configured to 40% ethanol (W/W).
(2) by the hydroxypropylcellulose of recipe quantity (Ashland companies of the U.S., KlucelTM, ELF models) and it is dissolved in 40% ethyl alcohol
In liquid (W/W), solution A is used as after evenly dispersed;
(3) solution A is taken, the voglibose of recipe quantity is added, solution B is used as after evenly dispersed;
(4) the newborn sugar and starch of recipe quantity is taken, is added in a step comminutor, 15min is mixed, controls wind turbine frequency:20Hz
~30Hz.
(5) solution B is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 40~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 80rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution B, until pellet moisture≤3.5%.Control wind turbine 20~30Hz of frequency, air inlet
40~80 DEG C of temperature.
The preparation of 4 voglibose particle of embodiment
Prescription:
Technique:
(1) ethyl alcohol 4.5kg is taken, purified water 10.5kg is added, is configured to 30% ethanol (W/W).
(2) by the hydroxypropylcellulose of recipe quantity (Ashland companies of the U.S., KlucelTM, EF models) and it is dissolved in 30% ethanol
(W/W) in, solution A is used as after evenly dispersed;
(3) solution A is taken, the voglibose of recipe quantity is added, solution B is used as after evenly dispersed;
(4) take recipe quantity mannitol (French Roquette companies,25C models, with before sieving with 100 mesh sieve,
Similarly hereinafter) and pregelatinized starch (Huzhou Zhanwang Pharmaceutical Co., Ltd., ZW-Y3 models, with before sieving with 100 mesh sieve, similarly hereinafter), a step is added
In comminutor, 25min is mixed, controls wind turbine frequency:20Hz~30Hz.
(5) solution B is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 50~85 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 55rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution B, until pellet moisture≤2.5%.Control wind turbine 20~30Hz of frequency, air inlet
50~85 DEG C of temperature.
The preparation of 5 voglibose particle of embodiment
Prescription:
Technique:
(1) taking acetone, (Sinopharm Chemical Reagent Co., Ltd. analyzes pure, purity:>=99.5%, similarly hereinafter) 7.5kg, add
Enter purified water 7.5kg, is configured to 50% acetone solution (W/W).
(1) by the hydroxypropyl methylcellulose of recipe quantity (Ashland companies of the U.S., BenecelTM, K100LV PH PRM models)
It is dissolved in 50% acetone solution (W/W), solution A is used as after evenly dispersed;
(2) solution A is taken, the voglibose of recipe quantity is added, solution B is used as after evenly dispersed;
(3) take the mannitol of recipe quantity, microcrystalline cellulose (Huzhou Linghu Xinwang Chemical Co., Ltd., PH101 models,
Similarly hereinafter) and pregelatinized starch, it is added in a step comminutor, mixes 20min, control wind turbine frequency:20Hz~30Hz.
(4) solution B is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 40~55 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 70rpm of inlet air temperature.
(5) dry after having sprayed above-mentioned solution B, until pellet moisture≤3.5%.Control wind turbine 20~30Hz of frequency, air inlet
40~55 DEG C of temperature.
The preparation of 6 voglibose particle of embodiment
Prescription:
Technique:
(1) ethyl alcohol 0.6kg is taken, purified water 2.4kg is added, is configured to 20% ethanol (W/W).
(2) by the povidone of recipe quantity (Ashland companies of the U.S., PlasdoneTM, K-17 models) and it is dissolved in 20% ethanol
(W/W) in, solution A is used as after evenly dispersed;
(3) solution A is taken, the voglibose of recipe quantity is added, solution B is used as after evenly dispersed;
(4) mannitol, trehalose (the Japanese Asahi Chemical Industry companies, with preceding mistake 100 of recipe quantity are taken
Mesh sieves, similarly hereinafter) and pregelatinized starch, it is added in a step comminutor, mixes 15min, control wind turbine frequency:20Hz~30Hz.
(5) solution B is taken to be injected to the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz, 50~70 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 40rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution B, until pellet moisture≤3.5%.Control wind turbine 20~30Hz of frequency, air inlet
50~70 DEG C of temperature.
The preparation of 7 voglibose particle of embodiment
Prescription:
Technique:
(1) isopropanol (Sinopharm Chemical Reagent Co., Ltd., analysis is pure, >=99.7%, similarly hereinafter) 0.9kg is taken, is added
Purified water 2.1kg is configured to 30% isopropyl alcohol liquid (W/W).
(2) by the hydroxypropyl methylcellulose of recipe quantity (Lotte Fine Chemical companies of South Korea, AnyCoat-CTM, AN6
Model) it is dissolved in 30% isopropyl alcohol liquid (W/W), it is used as solution A after evenly dispersed;
(3) solution A is taken, the voglibose of recipe quantity is added, solution B is used as after evenly dispersed;
(4) take the mannitol of recipe quantity, xylitol (Futaste Co., Ltd., with before sieving with 100 mesh sieve, under
Together) and pregelatinized starch, it is added in a step comminutor, mixes 20min, control wind turbine frequency:20Hz~30Hz.
(5) solution B is taken to be injected to the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz, 50~70 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 30rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution B, until pellet moisture≤3.5%.Control wind turbine 20~30Hz of frequency, air inlet
50~70 DEG C of temperature.
The preparation of 8 voglibose particle of embodiment
Prescription:
Technique:
(1) ethyl alcohol 2.0kg is taken, purified water 18.0kg is added, is configured to 10% ethanol (W/W).
(2) by the hydroxypropyl methylcellulose of recipe quantity (Lotte Fine Chemical companies of South Korea, AnyCoat-CTM, AN4
Model) it is dissolved in 10% ethanol (W/W), it is used as solution A after evenly dispersed;
(3) solution A is taken, the voglibose of recipe quantity is added, solution B is used as after evenly dispersed;
(4) mannitol of recipe quantity, newborn sugar and starch are taken, is added in a step comminutor, 20min, control wind turbine frequency are mixed
Rate:20Hz~30Hz.
(5) solution B is taken to be injected to the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz, 50~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 40rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution B, until pellet moisture≤2.5%.Control wind turbine 20~30Hz of frequency, air inlet
50~80 DEG C of temperature.
The preparation of 9 voglibose particle of embodiment
Prescription:
Technique:
(1) by the hydroxypropylcellulose of recipe quantity (Ashland companies of the U.S., KlucelTM, LXF models) and it is dissolved in purified water,
Solution A is used as after evenly dispersed;Solution is divided into 1:1 two parts, it is respectively labeled as A-0 and A-1.
(2) voglibose of recipe quantity is added in solution A -0, (is noted as solution A -2 after evenly dispersed:Solution A -0
Difference with A-2 is that the former is free of voglibose, and the latter contains voglibose, similarly hereinafter);
(3) the newborn sugar and starch of recipe quantity is taken, is added in a step comminutor, 30min is mixed, controls wind turbine frequency:20Hz
~30Hz.
(4) solution A -1 is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine
20~30Hz of frequency, 45~85 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 20rpm of inlet air temperature.
(5) dry after having sprayed above-mentioned solution A -1, until pellet moisture≤2.5%.Wind turbine 20~30Hz of frequency is controlled, into
40~80 DEG C of air temperature.
(6) solution A -2 is taken to be injected to the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 40~85 DEG C, 0.15~0.25Mpa of atomisation pressure, 20~80rpm of wriggling revolution speed of inlet air temperature.
(7) dry after having sprayed above-mentioned solution A -2, until pellet moisture≤4.0%.Wind turbine 20~30Hz of frequency is controlled, into
40~85 DEG C of air temperature.
The preparation of 10 voglibose particle of embodiment
Prescription:
Technique:
(1) ethyl alcohol 2.0kg is taken, purified water 18.0kg is added, is configured to 10% ethanol (W/W).
(2) by the hydroxypropylcellulose of recipe quantity (Ashland companies of the U.S., KlucelTM, EXF models) and it is dissolved in 10% ethyl alcohol
In liquid (W/W), solution A is used as after evenly dispersed;Solution is divided into 2:1 two parts, it is respectively labeled as A-0 and A-1.
(3) voglibose that recipe quantity is added in solution A -0 is evenly dispersed rear as solution A -2;
(4) the newborn sugar and starch of recipe quantity is taken, is added in a step comminutor, 25min is mixed, controls wind turbine frequency:20Hz
~30Hz.
(5) solution A -1 is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine
20~30Hz of frequency, inlet air temperature set 55~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 50rpm.
(6) dry after having sprayed above-mentioned solution A -1, until pellet moisture≤4.0%.Wind turbine 20~30Hz of frequency is controlled, into
65 DEG C of air temperature.
(7) solution A -2 is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine
20~30Hz of frequency, inlet air temperature set 55~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 50rpm.
(8) dry after having sprayed above-mentioned solution A -2, until pellet moisture≤4.0%.Wind turbine 20~30Hz of frequency is controlled, into
65 DEG C of air temperature.
The preparation of 11 voglibose particle of embodiment
Prescription:
Technique:
(1) ethyl alcohol 8.0kg is taken, purified water 12.0kg is added, is configured to 40% ethanol (W/W).
(2) by the hydroxypropylcellulose of recipe quantity (Ashland companies of the U.S., KlucelTM, ELF models, similarly hereinafter) it is dissolved in 40%
In ethanol (W/W), solution A is used as after evenly dispersed;Solution is divided into 1:2 two parts, it is respectively labeled as A-0 and A-1.
(3) voglibose of recipe quantity is added in solution A -0, solution A -2 is used as after evenly dispersed;
(4) the newborn sugar and starch of recipe quantity is taken, is added in a step comminutor, 15min is mixed, controls wind turbine frequency:20Hz
~30Hz.
(5) solution A -1 is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine
20~30Hz of frequency, 40~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 80rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution A -1, until pellet moisture≤3.5%.Wind turbine 20~30Hz of frequency is controlled, into
40~80 DEG C of air temperature.
(7) solution A -2 is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine
20~30Hz of frequency, 40~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 80rpm of inlet air temperature.
(8) dry after having sprayed above-mentioned solution A -2, until pellet moisture≤3.5%.Wind turbine 20~30Hz of frequency is controlled, into
40~80 DEG C of air temperature.
The preparation of 12 voglibose particle of embodiment
Prescription:
Technique:
(1) ethyl alcohol 4.5kg is taken, purified water 10.5kg is added, is configured to 30% ethanol (W/W).
(2) by the hydroxypropylcellulose of recipe quantity (Ashland companies of the U.S., KlucelTM, EF models) and it is dissolved in 30% ethanol
(W/W) in, solution A is used as after evenly dispersed;Solution is divided into 3:1 two parts, it is respectively labeled as A-0 and A-1.
(3) voglibose of recipe quantity is added in solution A -0, solution A -2 is used as after evenly dispersed;
(4) mannitol and pregelatinized starch of recipe quantity are taken, is added in a step comminutor, 25min, control wind turbine frequency are mixed
Rate:20Hz~30Hz.
(5) solution A -1 is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine
20~30Hz of frequency, 50~85 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 55rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution A -1, until pellet moisture≤2.5%.Wind turbine 20~30Hz of frequency is controlled, into
50~85 DEG C of air temperature.
(7) solution A -2 is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine
20~30Hz of frequency, 50~85 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 55rpm of inlet air temperature.
(8) dry after having sprayed above-mentioned solution A -2, until pellet moisture≤2.5%.Wind turbine 20~30Hz of frequency is controlled, into
50~85 DEG C of air temperature.
The preparation of 13 voglibose particle of embodiment
Prescription:
Technique:
(1) acetone 7.5kg is taken, purified water 7.5kg is added, is configured to 50% acetone solution (W/W).
(2) by the hydroxypropyl methylcellulose of recipe quantity (Ashland companies of the U.S., BenecelTM, K100LV PH PRM models)
It is dissolved in 50% acetone solution (W/W), solution A is used as after evenly dispersed;Solution is divided into 1:3 two parts, it is respectively labeled as A-0 and A-
1。
(3) voglibose of recipe quantity is added in solution A -0, solution A -2 is used as after evenly dispersed;
(4) take the mannitol of recipe quantity, microcrystalline cellulose (Huzhou Linghu Xinwang Chemical Co., Ltd., PH101 models,
Similarly hereinafter) and pregelatinized starch, it is added in a step comminutor, mixes 20min, control wind turbine frequency:20Hz~30Hz.
(5) solution A -1 is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine
20~30Hz of frequency, 40~55 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 70rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution A -1, until pellet moisture≤3.5%.Wind turbine 20~30Hz of frequency is controlled, into
40~60 DEG C of air temperature.
(7) solution A -2 is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine
20~30Hz of frequency, 40~55 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 70rpm of inlet air temperature.
(8) dry after having sprayed above-mentioned solution A -2, until pellet moisture≤3.5%.Wind turbine 20~30Hz of frequency is controlled, into
40~60 DEG C of air temperature.
The preparation of 14 voglibose particle of embodiment
Prescription:
Technique:
(1) ethyl alcohol 0.6kg is taken, purified water 2.4kg is added, is configured to 20% ethanol (W/W).
(2) by the povidone of recipe quantity (Ashland companies of the U.S., PlasdoneTM, K-17 models) and it is dissolved in 20% ethanol
(W/W) in, solution A is used as after evenly dispersed;Solution is divided into 5:1 two parts, it is respectively labeled as A-0 and A-1.
(3) voglibose of recipe quantity is added in solution A -0, solution A -2 is used as after evenly dispersed;
(4) mannitol, trehalose (the Japanese Asahi Chemical Industry companies, with preceding mistake 100 of recipe quantity are taken
Mesh sieves, similarly hereinafter) and pregelatinized starch, it is added in a step comminutor, mixes 15min, control wind turbine frequency:20Hz~30Hz.
(5) solution A -1 is taken to be injected to the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 50~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 40rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution A -1, until pellet moisture≤3.5%.Wind turbine 20~30Hz of frequency is controlled, into
50~80 DEG C of air temperature.
(7) solution A -2 is taken to be injected to the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 50~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 40rpm of inlet air temperature.
(8) dry after having sprayed above-mentioned solution A -2, until pellet moisture≤3.5%.Wind turbine 20~30Hz of frequency is controlled, into
50~80 DEG C of air temperature.
The preparation of 15 voglibose particle of embodiment
Prescription:
Technique:
(1) isopropanol 0.9kg is taken, purified water 2.1kg is added, is configured to 30% isopropyl alcohol liquid (W/W).
(2) by the hydroxypropyl methylcellulose of recipe quantity (Lotte Fine Chemical companies of South Korea, AnyCoat-CTM, AN6
Model) it is dissolved in 30% isopropyl alcohol liquid (W/W), it is used as solution A after evenly dispersed;Solution is divided into 1:It 5 two parts, is respectively labeled as
A-0 and A-1.
(3) voglibose of recipe quantity is added in solution A -0, solution A -2 is used as after evenly dispersed;
(4) mannitol, xylitol and pregelatinized starch of recipe quantity are taken, is added in a step comminutor, 20min, control are mixed
Wind turbine frequency processed:20Hz~30Hz.
(5) solution A -1 is taken to be injected to the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 50~70 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 30rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution A -1, until pellet moisture≤3.5%.Wind turbine 20~30Hz of frequency is controlled, into
50~70 DEG C of air temperature.
(7) solution A -2 is taken to be injected to the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 50~70 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 30rpm of inlet air temperature.
(8) dry after having sprayed above-mentioned solution A -2, until pellet moisture≤3.5%.Wind turbine 20~30Hz of frequency is controlled, into
50~70 DEG C of air temperature.
The preparation of 16 voglibose particle of embodiment
Prescription:
Technique:
(1) ethyl alcohol 2.0kg is taken, purified water 18.0kg is added, is configured to 10% ethanol (W/W).
(2) by the hydroxypropyl methylcellulose of recipe quantity (Lotte Fine Chemical companies of South Korea, AnyCoat-CTM, AN4
Model) it is dissolved in 10% ethanol (W/W), it is used as solution A after evenly dispersed;Solution is divided into 1:2 two parts, it is respectively labeled as A-
0 and A-1.
(3) voglibose of recipe quantity is added in solution A -0, solution A -2 is used as after evenly dispersed;
(4) mannitol of recipe quantity, newborn sugar and starch are taken, is added in a step comminutor, 20min, control wind turbine frequency are mixed
Rate:20Hz~30Hz.
(5) solution A -1 is taken to be injected to the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 50~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 40rpm of inlet air temperature.
(6) dry after having sprayed above-mentioned solution A -1, until pellet moisture≤2.5%.Wind turbine 20~30Hz of frequency is controlled, into
50~80 DEG C of air temperature.
(7) solution A -2 is taken to be injected to the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 50~80 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 40rpm of inlet air temperature.
(8) dry after having sprayed above-mentioned solution A -2, until pellet moisture≤2.5%.Wind turbine 20~30Hz of frequency is controlled, into
50~80 DEG C of air temperature.
The preparation of 17 voglibose particle of embodiment
Prescription:
Technique:
(1) by the hydroxypropylcellulose of recipe quantity (Ashland companies of the U.S., KlucelTM, EF models) and it is dissolved in purified water,
Solution A is used as after evenly dispersed;
(2) voglibose of recipe quantity is added in solution A, solution B is used as after evenly dispersed;
(3) the newborn sugar and starch of recipe quantity is taken, is added in a step comminutor, 20min is mixed, controls wind turbine frequency:20Hz
~30Hz.
(4) solution B is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 65~85 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 26rpm of inlet air temperature.
(5) dry after having sprayed above-mentioned solution B, until pellet moisture≤2.5%.Control wind turbine 20~30Hz of frequency, air inlet
65~80 DEG C of temperature.
The preparation of 18 voglibose particle of embodiment
Prescription:
Technique:
(1) by the hydroxypropyl methylcellulose of recipe quantity (Lotte Fine Chemical companies of South Korea, AnyCoat-CTM, AN3
Model) it is dissolved in purified water, it is used as solution A after evenly dispersed;
(2) voglibose of recipe quantity is added in solution A, solution B is used as after evenly dispersed;
(3) mannitol and pregelatinized starch of recipe quantity are taken, is added in a step comminutor, 30min, control wind turbine frequency are mixed
Rate:20Hz~30Hz.
(4) solution B is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 45~85 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 25rpm of inlet air temperature.
(5) dry after having sprayed above-mentioned solution B, until pellet moisture≤4.0%.Control wind turbine 20~30Hz of frequency, air inlet
40~80 DEG C of temperature.
The preparation of 19 voglibose particle of embodiment
Prescription:
Technique:
(1) by the povidone of recipe quantity (Ashland companies of the U.S., PlasdoneTM, K-12 models) and it is dissolved in purified water,
Solution A is used as after evenly dispersed;
(2) voglibose of recipe quantity is added in solution A, solution B is used as after evenly dispersed;
(3) mannitol and starch of recipe quantity are taken, is added in a step comminutor, 20min is mixed, controls wind turbine frequency:
20Hz~30Hz.
(4) solution B is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 45~85 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 25rpm of inlet air temperature.
(5) dry after having sprayed above-mentioned solution B, until pellet moisture≤4.0%.Control wind turbine 20~30Hz of frequency, air inlet
45~80 DEG C of temperature.
The preparation of 20 voglibose particle of embodiment
Prescription:
Technique:
(1) by the hydroxypropyl methylcellulose of recipe quantity (Lotte Fine Chemical companies of South Korea, AnyCoat-CTM, AN15
Model) it is dissolved in purified water, it is used as solution A after evenly dispersed;
(2) voglibose of recipe quantity is added in solution A, solution B is used as after evenly dispersed;
(3) mannitol and pregelatinized starch of recipe quantity are taken, is added in a step comminutor, 15min, control wind turbine frequency are mixed
Rate:20Hz~30Hz.
(4) solution B is taken to be injected in the step comminutor containing above-mentioned material in such a way that top spray is granulated.Control wind turbine frequency
20~30Hz of rate, 45~85 DEG C, 0.15~0.25Mpa of atomisation pressure, wriggling revolution speed 25rpm of inlet air temperature.
(5) dry after having sprayed above-mentioned solution B, until pellet moisture≤4.0%.Control wind turbine 20~30Hz of frequency, air inlet
45~80 DEG C of temperature.
The measurement of the 21 granule content uniformity of embodiment
When the bottom pot for after drying, taking out a step comminutor, for the particle in this patent Examples 1 to 20, respectively
According to the method for uniformity of dosage units sampling, 10 samples are taken.
All granule contents are measured using following method:
Chromatographic condition shines high performance liquid chromatography (Chinese Pharmacopoeia four general rules of version in 2015 with system suitability
0512) it measures.With polyamino bonding polyvinyl alcohol be filler (Shodex Asahipak NH2P-50 4E, 250 × 4.6mm,
5 μm or the comparable chromatographic column of performance);35 DEG C of column temperature;With phosphate buffer (sodium dihydrogen phosphate 1.56g is taken, water 500mL is added to make
Dissolving, with disodium hydrogen phosphate 3.58g, adds water 500mL to make dissolving, takes sodium dihydrogen phosphate 500mL, use disodium phosphate soln
PH value is adjusted to 6.5)-acetonitrile (37:63) it is mobile phase;With fluorescence detector, a length of 350nm of excitation light wave, wavelength of transmitted light
For 430nm;Taurine 6.25g and sodium metaperiodate 2.56g are taken, be dissolved in water and is diluted to 1000mL, is shaken up, as fluorescence reaction
Reagent;Post-column derivation;React about 100 DEG C of bath temperature, polytetrafluoroethylene (PTFE) reaction tube length 20m (internal diameter 0.5mm);Cooling bath temperature is about
It it is 15 DEG C, polytetrafluoroethylene (PTFE) cools down pipe range 2m (internal diameter 0.3mm);Flow velocity is 1mL per minute, the flow velocity of mobile phase and fluorescent reagent
It is identical.Number of theoretical plate is calculated by voglibose peak should be not less than 3000, the separating degree between voglibose peak and auxiliary material peak
It should meet the requirements, the relative standard deviation of reference substance solution replication 6 times, peak area should be not more than 3.0%.
Measuring method
Take this product appropriate, it is finely ground, it weighs appropriate (being approximately equivalent to voglibose 2mg), it is accurately weighed, set 50mL measuring bottles
In, add flowing to make an appointment 40mL, shake well 30 minutes makes voglibose dissolve, is diluted to scale with mobile phase, shakes up, put
It sets, takes supernatant to be filtered through 0.45 μm of filter membrane, take subsequent filtrate as test solution;Separately take voglibose reference substance about
22mg, it is accurately weighed, it sets in 50mL measuring bottles, adds flowing phased soln and be diluted to scale, shake up, precision measures 5mL, sets 50mL amounts
In bottle, it is diluted to scale with mobile phase, is shaken up, as a contrast product solution.Precision measures reference substance solution and test solution is each
50 μ L are injected separately into liquid chromatograph, record chromatogram.By external standard method with calculated by peak area granule content (mg/g).
Calculation formula:
In formula:
ASampleThe peak area at main composition peak in → test solution;
AIt is rightThe average value of the main peak area of → contrast solution;
WIt is right→ prepare weighing (mg) for voglibose reference substance used in contrast solution;
WSample→ the sample for preparing test solution is weighed (mg);
P → reference substance content;
F → reference substance solution extension rate.
Calculate after granule content obtained by Examples 1 to 20, the granule content of the value divided by theory obtains each
The percentage composition of grain, the granule content uniformity the results are shown in Table 1.
1 Determination of Content Uniformity result (n=10) of table
By table as it can be seen that in all embodiments voglibose particle content RSD≤0.50%;According to Chinese Pharmacopoeia 2015
The requirement of four 0941 Content uniformity tests of version calculates A+2.2S, and result is much smaller than 15, illustrates according to 1~20 institute of embodiment
The granule content uniformity obtained is preferable.
The measurement of 22 particle friability of embodiment
According to document (Drug Dev Ind Pharm.1987,13:1-14) method introduced is measured.
When the bottom pot for after drying, taking out a step comminutor, for the particle in this patent Examples 1 to 20, respectively
According to the method for uniformity of dosage units sampling, 10 samples are taken, the sample measured as friability after mixing.
Assay method:Particle in Example 1~20 is appropriate, crosses 35 mesh and 60 mesh medicines sieve, takes 35~60 mesh particle (grains
Diameter is about 250~500 μm) 10.0g, it is accurately weighed, it is placed in friability somascope (FT-2000AE models, the extremely big Tian Fa sections in Tianjin
Skill Development Co., Ltd) in, additional average diameter is the bead about 200, rotational time 10min of 4mm, and rotating speed is
25rpm after rotation, removes bead, crosses 60 mesh sieve, weighs the quality of remainder particulate, calculates friability.
It is comparative example 1 according to the particle that patent CN200710129313.7 voglibose dispersible tablets are prepared.
Particle friability in Examples 1 to 20 and comparative example 1 the results are shown in Table 2.
2 friability measurement result of table
Friability | |
Unit | % |
Embodiment 1 | 28.51 |
Embodiment 2 | 26.72 |
Embodiment 3 | 16.42 |
Embodiment 4 | 13.25 |
Embodiment 5 | 28.28 |
Embodiment 6 | 27.48 |
Embodiment 7 | 12.33 |
Embodiment 8 | 15.57 |
Embodiment 9 | 27.84 |
Embodiment 10 | 26.16 |
Embodiment 11 | 15.64 |
Embodiment 12 | 12.59 |
Embodiment 13 | 27.76 |
Embodiment 14 | 25.66 |
Embodiment 15 | 11.39 |
Embodiment 16 | 24.44 |
Embodiment 17 | 26.36 |
Embodiment 18 | 10.54 |
Embodiment 19 | 12.25 |
Embodiment 20 | 21.68 |
Comparative example 1 | 65.69 |
As seen from the above table, the friability of voglibose particle is respectively less than 30% in all embodiments, and comparative example 1
Friability be more than 60%, it is seen that using a step be granulated method made from particle friability it is smaller.In addition, from the crisp of pelleting
Broken degree is related with the water-soluble binder dosage and model that are added, and water-soluble binder molecular weight is higher, and content is bigger, obtained
Particle has the tendency that friability is smaller.
The preparation of 23~25 Voglibose tablet of embodiment
Voglibose particle obtained in this patent Examples 1 to 3 is taken respectively, and in pelletizing machine, (YK160 types are swing
On granulator, Kuibao Group Co., Ltd., Jiangsu, similarly hereinafter) 40 mesh sieve, in mixing machine, (the quasi- mixing machine in the type sides HZD-150L is breathed out
10min is mixed on your shore nano medication chemistry equipment Co., Ltd, similarly hereinafter), the stearic acid of particle gross weight 0.5% is added later
Magnesium remixes 5min.Using high speed tablet press (GZP-26 type tablet press machines, Beijing Hanlin Hangyu Science And Technology Development Co., Ltd, under
Together), scrobicula round diameter is impressed mold tabletting among 7.0mm, and the pressure for controlling tabletting is 4~6KN, forces charging speed
Degree is 10rpm, and the tablet of hardness >=2KN is made, and the sample of embodiment 23~25 is made respectively.
Since rate of dissolution may be variant in different media for voglibose, when doing Dissolution experiments,
Voglibose tablet dissolved corrosion in different medium is inconsistent.Have document (Liaoning chemical industry, 2017, (3):211-213)
Report:The Voglibose tablet stripping curve that different manufacturers produce in pH5.8 buffer solutions has larger difference, therefore, with pH5.8
Distinction medium of the buffer solution as Voglibose tablet.
Using the Voglibose tablet of Japanese Takede Chemical Industries Ltd production as the reference preparation of embodiment 23~25.
The stripping curve of Voglibose tablet and reference preparation made from embodiment 23~25 is carried out according to following measuring method
Experiment:
Chromatographic condition shines high performance liquid chromatography (Chinese Pharmacopoeia four general rules of version in 2015 with system suitability
0512) it measures.It is filler (Shodex Asahipak NH with polyamino bonding polyvinyl alcohol2P-50 4E, 250 × 4.6mm,
5 μm or the comparable chromatographic column of performance);35 DEG C of column temperature;With phosphate buffer (sodium dihydrogen phosphate 1.56g is taken, water 500mL is added to make
Dissolving, with disodium hydrogen phosphate 3.58g, adds water 500mL to make dissolving, takes sodium dihydrogen phosphate 500mL, use disodium phosphate soln
PH value is adjusted to 6.5)-acetonitrile (37:63) it is mobile phase;With fluorescence detector, a length of 350nm of excitation light wave, wavelength of transmitted light
For 430nm;Taurine 6.25g and sodium metaperiodate 2.56g are taken, be dissolved in water and is diluted to 1000mL, is shaken up, as fluorescence reaction
Reagent;Post-column derivation;React about 100 DEG C of bath temperature, polytetrafluoroethylene (PTFE) reaction tube length 20m (internal diameter 0.5mm);Cooling bath temperature is about
It it is 15 DEG C, polytetrafluoroethylene (PTFE) cools down pipe range 2m (internal diameter 0.3mm);Flow velocity is 1mL per minute, the flow velocity of mobile phase and fluorescent reagent
It is identical.Number of theoretical plate is calculated by voglibose peak should be not less than 3000, the separating degree between voglibose peak and auxiliary material peak
It should meet the requirements, the relative standard deviation of reference substance solution replication 6 times, peak area should be not more than 3.0%.
Measuring method takes this product, according to dissolution method (four general rules of Chinese Pharmacopoeia version in 2015,0,931 second method), with
PH5.8 phosphate buffers 900mL is dissolution medium, and rotating speed is 50 turns per minute, is operated in accordance with the law, through 5,10,15,20 and 30 minutes
When, it takes solution appropriate, is filtered through 0.45 μm of filter membrane, take subsequent filtrate as test solution;Separately take voglibose reference substance about
22mg, it is accurately weighed, it sets in 50mL measuring bottles, adds flowing phased soln and be diluted to scale, shake up, precision measures 5mL, sets 50mL amounts
In bottle, it is diluted to scale with mobile phase, is shaken up, then accurate measurement 1mL, set in 200mL measuring bottles, solubilization goes out medium to quarter
Degree, shakes up, then accurate measurement 3mL, sets in 10mL measuring bottles, with dilution in acetonitrile to scale, shakes up, as a contrast product solution.It is accurate
Reference substance solution and each 100 μ L of test solution are measured, liquid chromatograph is injected separately into, records chromatogram.By external standard method with peak
The stripping quantity of areal calculation every.
The dissolution results of Voglibose tablet and reference preparation made from this patent embodiment 23~25 are shown in Table 3 and Fig. 1.
The dissolution results of 3 embodiment of table 23~25 Voglibose tablet and reference preparation
Embodiment 23 | Embodiment 24 | Embodiment 25 | Reference preparation | |
Corresponding embodiment | Embodiment 1 | Embodiment 2 | Embodiment 3 | —— |
Unit | % | % | % | % |
5min | 70.25 | 64.25 | 56.70 | 32.75 |
10min | 99.42 | 95.77 | 90.26 | 65.29 |
15min | 99.24 | 99.52 | 99.14 | 82.28 |
20min | 99.62 | 99.23 | 98.38 | 94.21 |
30min | 99.38 | 99.24 | 98.96 | 99.23 |
The preparation of 26~30 voglibose oral disintegrating tablet of embodiment
Voglibose particle obtained in this patent embodiment 4~8 is taken respectively, and 40 mesh sieve is crossed on pelletizing machine,
10min is mixed on mixing machine, is sequentially added disintegrant in table 4 (numerical value is the multiple of voglibose batch dosage), is being mixed
10min is mixed on machine, adds the magnesium stearate mixing 5min of the 0.5% of particle weight.Scrobicula is used on high speed tablet press
Round diameter is impressed mold tabletting among 7.0mm, and the pressure for controlling tabletting is 4~6KN, and pressure charging rate is
The tablet of hardness >=2KN is made in 10rpm.
The disintegrant and its disintegrating method result being added in 4 embodiment 26~30 of table
Embodiment 26 | Embodiment 27 | Embodiment 28 | Embodiment 29 | Embodiment 30 | |
Corresponding embodiment | Embodiment 4 | Embodiment 5 | Embodiment 6 | Embodiment 7 | Embodiment 8 |
Low-substituted hydroxypropyl cellulose | 10 | 50 | —— | —— | —— |
Crospovidone | —— | —— | 100 | —— | —— |
Croscarmellose sodium | —— | —— | —— | 150 | —— |
Sodium carboxymethyl starch | —— | —— | —— | —— | 200 |
The intraoral disintegration time | 40 seconds | 36 seconds | 18 seconds | 26 seconds | 24 seconds |
Note:The amount that each disintegrant is added is the multiple of voigelibo sugar weight.Such as embodiment 26, Example 4 is made
Particle, voglibose dosage is 0.02kg in the embodiment, then additional low-substituted hydroxypropyl cellulose is 0.2kg.Firmly
Fatty acid magnesium dosage is the 0.5% of particle gross weight, and such as embodiment 26, particle gross weight is 17.02kg, then magnesium stearate is added
0.851kg.Disintegrant and magnesium stearate is added using identical method in other embodiment.
Low-substituted hydroxypropyl cellulose selects the low substitution of the LH-32 models (20 μm of average grain diameter) of Shinetsu companies of Japan
Hydroxypropylcellulose (similarly hereinafter);
Crospovidone selects BASF Corp. of GermanyCL-SF (10~30 μm) model Crospovidone (under
Together).
Croscarmellose sodium selects DEF companies of HollandCroscarmellose sodium (under
Together).
JRS companies of sodium carboxymethyl starch GermanySodium carboxymethyl starch (similarly hereinafter).
Select voglibose oral disnitegration tablet (the ベ イ ス Application OD Ingot of Japanese Takede Chemical Industries Ltd's production
0.2) reference preparation as embodiment 26~30.
According to the method for dissolution rate in embodiment 23~25, with citrate phosphate buffer (dilute McIlvaine buffer solutions, pH
5.0) it is dissolution medium, voglibose oral disintegrating tablet and reference preparation made from embodiment 26~30 is measured, as a result seen
Fig. 2.
From Figure 2 it can be seen that all formulations dissolution rate in 5min is attained by 90% or more, in 10min, dissolution rate exists
95% or more, the characteristics of meeting oral disintegrating tablet Fast Stripping.
The preparation of 31~33 voglibose capsule of embodiment
Voglibose particle obtained in this patent embodiment 9~11 is taken respectively, and 40 mesh sieve is crossed on pelletizing machine,
10min is mixed on mixing machine, and 0.5% magnesium stearate of particle weight is added later, 5min is remixed, using fully-automatic capsule
Filling machine (Zhejiang Feiyun Technology Co., Ltd., NJP7500 types) fills capsule, and the sample of embodiment 31~33 is made respectively.
According to the method for dissolution rate in embodiment 23~25, with citrate phosphate buffer (dilute McIlvaine buffer solutions, pH
5.0) be dissolution medium, to voglibose capsule made from embodiment 31~33 and reference preparation (Voglibose tablet,
0.2mg, Japanese Takede Chemical Industries Ltd) it is measured.As a result see Fig. 3.As seen from Figure 3, all formulations are in 5min
Dissolution rate is attained by 50% or more, and in 10min, dissolution rate is 80% or more, and in 15min, dissolution rate is made 85% or more
The capsule energy Fast Stripping obtained.
The preparation of 34~38 voglibose dispersible tablet of embodiment
Voglibose particle obtained in this patent embodiment 12~16 is taken respectively, and 40 mesh sieve is crossed on pelletizing machine,
10min is mixed on mixing machine, sequentially adds the disintegrant (numerical value is the multiple of voglibose batch dosage) in table 5,
10min is mixed on mixing machine, adds the magnesium stearate mixing 5min of the 0.5% of particle weight.It is used on high speed tablet press
Scrobicula round diameter is impressed mold tabletting among 7.0mm, and the pressure for controlling tabletting is 4~6KN, and pressure charging rate is
The tablet of hardness >=2KN is made in 10rpm.
The sample of embodiment 34~38 is carried out using disintegration tester (Tianjin Tianda Tianfa Science and Technology Co. Ltd., ZB-1E types)
Disintegrating property measures (37 DEG C ± 0.5 DEG C, 800mL purified waters), the results are shown in Table 5.
The disintegrant and its disintegrating method result being added in 5 embodiment 34~38 of table
Upper table shows that dispersible tablet made from embodiment 34~38 meets requirement (3min of the dispersible tablet generally to disintegration time limited
Within).Since the dispersible tablet of embodiment 34~38 is obtained by the particle preparation of embodiment 12~16, embodiment 12~
16 particle has the characteristics of fater disintegration.
Select voglibose oral disnitegration tablet (the ベ イ ス Application OD Ingot of Japanese Takede Chemical Industries Ltd's production
0.2mg) the reference preparation as 34~38 dispersible tablet of embodiment.
According to the method for dissolution rate in embodiment 23~25, with citrate phosphate buffer (dilute McIlvaine buffer solutions, pH
5.0) it is dissolution medium, voglibose dispersible tablet and reference preparation made from embodiment 34~38 is measured.As a result see
Fig. 4.From fig. 4, it can be seen that all formulations dissolution rate in 5min is attained by 90% or more, in 10min dissolution rate 95% with
On, the characteristics of meeting dispersible tablet Fast Stripping.Since the dispersible tablet of embodiment 34~38 is by of 12~16 gained of embodiment
Grain is prepared after 0.5% magnesium stearate is added, and therefore, the particle in embodiment 12~16 is likewise supplied with the spy of Fast Stripping
Point.
The preparation of 39~42 voglibose granule of embodiment
The method according to above-described embodiment 17~20 prepares blank granules respectively, and lactose in prescription or mannitol are substituted for
Sucrose (Zhang Fu sugar industries Co., Ltd of Zhangzhou City with preceding crushing and sieves with 100 mesh sieve).It takes and contains according to prepared by embodiment 17~20 respectively
Medicine particle and blank granules, the ratio by two kinds of particles according to following table 6 mix 10min, 39~42 voigelibo of embodiment are made
Sugared granule (every bag of 1.0g).
The preparation of 6 voglibose granule of table
Embodiment 39 | Embodiment 40 | Embodiment 41 | Embodiment 42 | |
The preparation method of particle | Embodiment 17 | Embodiment 18 | Embodiment 19 | Embodiment 20 |
Medicine-containing particle | 157.2 | 194.9 | 212.9 | 166.5 |
Blank granules | 842.8 | 805.1 | 787.1 | 833.5 |
Voigelibo sugared content | 0.3mg/ bags | 0.3mg/ bags | 0.3mg/ bags | 0.3mg/ bags |
According to the method for dissolution rate in embodiment 23~25, with citrate phosphate buffer (dilute McIlvaine buffer solutions, pH
5.0) it is dissolution medium, voglibose granule made from embodiment 39~42 is measured.As a result see Fig. 5.It can by Fig. 5
See, all formulations dissolution rate in 5min is attained by 90% or more, and in 10min, dissolution rate meets particle 95% or more
The characteristics of agent Fast Stripping.
Claims (10)
1. a kind of preparation method of voglibose particle is prepared by step granulation, it is characterized in that:Including following step
Suddenly:
(1) water-soluble binder is dissolved in polar solvent, solution A is used as after evenly dispersed;
(2) solution A is divided into two parts, as A-1, another is added voglibose, is used as after evenly dispersed molten a copy of it
Liquid A-2;
(3) diluent and disintegrant are taken, is added in a step comminutor, mixing;Control wind turbine frequency:20Hz~30Hz;When mixing
Between:5~30min.
(4) solution A -1 is taken to be injected in the step comminutor described in (3) in such a way that top spray is granulated;Control wind turbine frequency 20
~30Hz, 40~85 DEG C, 0.15~0.25Mpa of atomisation pressure, 20~80rpm of wriggling revolution speed of inlet air temperature.
(5) dry after having sprayed above-mentioned solution A -1, until pellet moisture≤4.0%;Wind turbine 20~30Hz of frequency is controlled, into wind-warm syndrome
40~85 DEG C of degree.
(6) solution A -2 is taken to be injected in the step comminutor described in (4) in such a way that top spray is granulated;Control wind turbine frequency 20
~30Hz, 40~85 DEG C, 0.15~0.25Mpa of atomisation pressure, 20~80rpm of wriggling revolution speed of inlet air temperature.
(7) dry after having sprayed above-mentioned solution A -2, until pellet moisture≤4.0%;Wind turbine 20~30Hz of frequency is controlled, into wind-warm syndrome
40~85 DEG C of degree.
2. a kind of preparation method of voglibose particle according to claim 1, it is characterized in that:Solution A be divided into A-1 and
The weight ratio of two parts of A-2, this two parts of solution are 0:1 or 1:(0.2~5).
3. a kind of preparation method of voglibose particle according to claim 1, it is characterized in that:Water-soluble binder is
One kind in povidone, hydroxypropylcellulose, hydroxypropyl methylcellulose and its a variety of mixtures;Polar solvent is water, ethyl alcohol, isopropyl
One kind in alcohol, acetone and its a variety of mixtures;Diluent is the lactose sieved with 100 mesh sieve, mannitol, xylitol, trehalose, micro-
One kind in crystalline cellulose and its a variety of mixtures;Disintegrant is the starch or pregelatinized starch sieved with 100 mesh sieve.
4. a kind of preparation method of voglibose particle according to claim 1, it is characterized in that:Voglibose makes
Dosage is 1 part, and water-soluble binder is 5~100 parts (weight ratios, similarly hereinafter);Polar solvent is 100~2000 parts;Diluent is
200~1000 parts;Disintegrant is 10~1000 parts.
5. a kind of preparation method of voglibose particle according to claim 1, it is characterized in that:Voglibose makes
Dosage is 1 part, and water-soluble binder is 10~80 parts (weight ratios, similarly hereinafter);Polar solvent is 200~1600 parts;Diluent is
250~800 parts;Disintegrant is 25~800 parts.
6. a kind of preparation method of voglibose particle according to claim 1, it is characterized in that:Voglibose makes
Dosage is 1 part, and water-soluble binder is 15~60 parts (weight ratios, similarly hereinafter);Polar solvent is 300~1500 parts;Diluent is
300~700 parts;Disintegrant is 50~500 parts.
7. a kind of preparation method of Voglibose tablet, it is characterized in that:A kind of voglibose described in accordance with the claim 1
The preparation method of particle, be added the lubricant (such as 0.5% magnesium stearate) that particle gross weight 0.3%~1.0% is made and/or
0.1%~2.0% glidant (such as 0.2% gaseous silicon oxide).
8. a kind of preparation method of voglibose dispersible tablet, it is characterized in that:A kind of voigelibo described in accordance with the claim 1
The preparation method of sugared particle also needs 10~200 parts additional of disintegrant;Disintegrant is typically chosen that disintegration ability is stronger low to be taken
For hydroxypropylcellulose, crospovidone, croscarmellose sodium, sodium carboxymethyl starch.
9. a kind of preparation method of voglibose granule, it is characterized in that:A kind of voigelibo described in accordance with the claim 1
The preparation method of sugared particle also needs to use cane sugar substitution filler therein, prepares blank granules, and shines certain proportion by blank
Particle and medicine-containing particle are mixed and made into voglibose granule.
10. preparation method or a kind of voglibose of a kind of Voglibose tablet according to claim 7 or 8 or 9
The preparation method of dispersible tablet or a kind of preparation method of voglibose granule, it is characterized in that:Be made tablet, dispersible tablet or
After granula, it is 0.2mg or 0.3mg that each preparation unit, which contains voglibose,.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810863323.1A CN108635332A (en) | 2018-08-01 | 2018-08-01 | A kind of preparation method of voglibose particle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810863323.1A CN108635332A (en) | 2018-08-01 | 2018-08-01 | A kind of preparation method of voglibose particle |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108635332A true CN108635332A (en) | 2018-10-12 |
Family
ID=63760567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810863323.1A Withdrawn CN108635332A (en) | 2018-08-01 | 2018-08-01 | A kind of preparation method of voglibose particle |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108635332A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111227101A (en) * | 2018-11-28 | 2020-06-05 | 中粮集团有限公司 | Protein product and preparation method thereof |
CN111374952A (en) * | 2018-12-29 | 2020-07-07 | 甘李药业江苏有限公司 | Acarbose pharmaceutical composition and preparation method thereof |
CN114699383A (en) * | 2022-06-06 | 2022-07-05 | 中孚药业股份有限公司 | Preparation method of voglibose capsule |
CN114831956A (en) * | 2022-05-25 | 2022-08-02 | 山东新华制药股份有限公司 | Voglibose-containing effervescent tablet and preparation method thereof |
CN115154436A (en) * | 2022-05-25 | 2022-10-11 | 山东新华制药股份有限公司 | Compound for promoting dissolution of voglibose and preparation method thereof |
-
2018
- 2018-08-01 CN CN201810863323.1A patent/CN108635332A/en not_active Withdrawn
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111227101A (en) * | 2018-11-28 | 2020-06-05 | 中粮集团有限公司 | Protein product and preparation method thereof |
CN111374952A (en) * | 2018-12-29 | 2020-07-07 | 甘李药业江苏有限公司 | Acarbose pharmaceutical composition and preparation method thereof |
CN111374952B (en) * | 2018-12-29 | 2022-07-26 | 甘李药业江苏有限公司 | Acarbose pharmaceutical composition and preparation method thereof |
CN114831956A (en) * | 2022-05-25 | 2022-08-02 | 山东新华制药股份有限公司 | Voglibose-containing effervescent tablet and preparation method thereof |
CN115154436A (en) * | 2022-05-25 | 2022-10-11 | 山东新华制药股份有限公司 | Compound for promoting dissolution of voglibose and preparation method thereof |
CN114831956B (en) * | 2022-05-25 | 2024-03-22 | 山东新华制药股份有限公司 | Effervescent tablet containing voglibose and preparation method thereof |
CN115154436B (en) * | 2022-05-25 | 2024-05-07 | 山东新华制药股份有限公司 | Compound for promoting dissolution of voglibose and preparation method thereof |
CN114699383A (en) * | 2022-06-06 | 2022-07-05 | 中孚药业股份有限公司 | Preparation method of voglibose capsule |
CN114699383B (en) * | 2022-06-06 | 2022-08-05 | 中孚药业股份有限公司 | Preparation method of voglibose capsule |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108635332A (en) | A kind of preparation method of voglibose particle | |
CN101375849B (en) | Novel dosage form of sinomenine medicament or hydrochlorate thereof and preparation technique thereof | |
CN1407894A (en) | Pharmaceutical composition | |
KR20130123471A (en) | Ganaxolone formulations and methods for the making and use thereof | |
CN101695480B (en) | Olopatadine hydrochloride dispersible tablets, preparation method thereof and quality control method thereof | |
CN109674753A (en) | Solid dispersion | |
CN105640913B (en) | A kind of olmesartan medoxomil tablet and preparation method thereof | |
CN103156819A (en) | Benzoic acid alogliptin composition troche and preparation method thereof | |
CN109662949A (en) | A kind of fludrocortisone acetate oral disnitegration tablet and preparation method thereof | |
CN108272765A (en) | Pharmaceutical composition, oral disintegrating tablet and its preparation, the application of hydrochloric Vardenafil | |
Li et al. | Pectin microparticles for peptide delivery: Optimization of spray drying processing | |
WO2023109573A1 (en) | Traditional chinese medicine composition for treating hashimoto's thyroiditis, and preparation method therefor | |
CN101597272B (en) | Sodium salt compound of Iguratimod, preparation method thereof and pharmaceutical use thereof | |
CN105496941B (en) | A kind of folic acid solid pharmaceutical preparation and preparation method thereof | |
CN106924237B (en) | It is a kind of containing En Gelie is net and the pharmaceutical composition of Metformin hydrochloride | |
CN108670958A (en) | A kind of preparation method of voglibose effervescent tablet | |
CN102657778B (en) | Honeysuckle throat clearing tablets and preparation method thereof | |
CN109646417A (en) | A kind of Trimetazidine sustained release tablets and preparation method thereof | |
CN104721202A (en) | Medicine for preventing and treating acute altitude stress | |
CN109846843B (en) | Desloratadine orally disintegrating tablet | |
CN114470062A (en) | Mongolian medicine, preparation process and application thereof | |
CN113230218A (en) | Ca-AKG chewable tablet and preparation method thereof | |
CN105168156B (en) | A kind of Scullcap total-flavonoid dispersible tablet and its manufacturing method | |
CN101057868B (en) | Preparation method of traditional Chinese medicine preparation for treating osteoporosis diseases and detection method | |
CN108703956A (en) | A kind of solid composite medicament containing Bosentan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181012 |